Discover the distinctive symptoms of liver pain, common underlying conditions, and effective treatment options to protect ...

Liz Bates was given just a 40 per cent chance of survival after being diagnosed with leukaemia - and was left fighting for ...

Plus: "I’ve just finished a course of antibiotics for a stubborn flu and feel tired most of the time. What can I take to give ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License ...

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

Shorla Oncology (?Shorla'), a U.S.-Ireland specialty pharmaceutical company, today announced the launch of a dedicated sales force and market access teams and the commercial availability of IMKELDI, ...

Another hemorrhagic threat is Lassa Fever, a virus in West Africa infecting between 100,000 and 300,000 people annually, ...

Liver cancer often remains undetected until advanced stages. Learn about the causes and how you can protect yourself with ...

Affected populations: PFIC is a group of rare genetic diseases that cause progressive liver failure. The exact prevalence of ...

Oct. 24, 2024 — A new mouse model mimicking the liver symptoms of myotonic dystrophy type 1 -- the most prevalent form of adult-onset muscular dystrophy -- provides insight into why patients ...

For months, Ash, 26, could hardly eat and felt so exhausted she could hardly work, so she knew it had to be more than regular bloating.

Previously-untreated patients with hepatocellular carcinoma (HCC), a common form of liver cancer, will have an immunotherapy-based treatment option after NICE gave the nod to NHS funding of Roche ...